This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to tricyclic antidepressants. It is often investigated for its potential therapeutic effects on the central nervous system, particularly in the treatment of mood disorders such as depression and anxiety. Researchers explore its ability to modulate neurotransmitter activity, specifically targeting serotonin and norepinephrine pathways, which are critical in regulating mood and emotional stability. Additionally, its carboxamide group makes it a candidate for further chemical modifications, enabling the development of derivatives with enhanced efficacy or reduced side effects. Its application extends to preclinical studies, where it serves as a key intermediate in synthesizing novel compounds for neurological research.